Related Experiment Video

Updated: Jun 10, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Left ventricular noncompaction cardiomyopathy: what do we know?

Timothy E Paterick1, Thomas C Gerber, Sala Ray Pradhan

  • 1Division of Cardiovascular Disease, Mayo Clinic Florida, Jacksonville, FL, USA.

Reviews in Cardiovascular Medicine
|August 12, 2010
PubMed

Insights

Left ventricular noncompaction (LVNC) is a rare genetic heart muscle disease. Diagnosis and management are complex due to its overlap with other cardiomyopathies and variable presentation.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Left ventricular noncompaction (LVNC) is a rare primary genetic cardiomyopathy.
  • Diagnosis is typically made via echocardiography, with other imaging modalities evolving.
  • LVNC diagnosis is debated due to overlap with other cardiomyopathies like dilated and hypertrophic cardiomyopathy.

Purpose of the Study:

  • To review the diagnostic modalities for LVNC.
  • To discuss the management challenges and considerations for LVNC patients.
  • To highlight the variability in symptoms, diagnosis, and prognosis.

Main Methods:

  • Review of diagnostic imaging techniques including echocardiography, left ventriculography, cardiac MRI, and CT.
  • Analysis of clinical presentation, genetic factors, and overlapping conditions.
  • Discussion of current management strategies and recommendations.

Main Results:

  • Echocardiography remains the primary diagnostic tool for LVNC.
  • Cardiac MRI and CT offer advanced noninvasive imaging for noncompacted myocardium.
  • LVNC presentation, diagnosis, and prognosis are highly variable, complicating treatment.

Conclusions:

  • Effective management of LVNC requires addressing genetic testing, family screening, ICD placement, anticoagulation, and physical activity.
  • The heterogeneous nature of LVNC necessitates individualized treatment approaches.
  • Further research is needed to clarify LVNC as a distinct entity and standardize management.

More Related Videos

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...